Conference
Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium
Authors
Sridhar SS; Mackenzie MJ; Hotte SJ; Mukherjee SD; Kollmannsberger C; Haider MA; Chen EX; Wang L; Srinivasan R; Ivy SP
Volume
26
Pagination
pp. 5047-5047
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2008
DOI
10.1200/jco.2008.26.15_suppl.5047
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X